Drug intelligence / Profile preview

Yunnan Baiyao

Development stage
Phase 4
Lead developer
Yunnan Baiyao
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Yunnan Baiyao is a proprietary traditional Chinese medicine formula developed in 1902 by Qu Huangzhang and produced in China. It is primarily used for its hemostatic (bleeding control) properties and is widely applied to promote wound healing, relieve pain, and stop bleeding both internally and externally. The main active ingredient is believed to be Panax notoginseng (Tienchi ginseng), though the full formula remains a closely guarded trade secret. Other reported ingredients include Ajuga forrestii Diels plant, Chinese yam root (Dioscoreae nipponica Makino), Erodium stephanianum and Geranium wilfordii plants, Dioscoreae parvilora ting root, Inula cappa plant[4]. Mechanistically, it appears to activate platelets—critical components of blood clotting—and may enhance expression of platelet surface glycoproteins[2][4][5]. There are also claims of anti-inflammatory and anti-cancer effects; some studies suggest it can induce apoptosis in certain cancer cell lines such as canine hemangiosarcoma cells[2][4]. It has been used extensively in both human and veterinary medicine but lacks approval or formal evaluation by regulatory agencies such as the FDA or EMA[5].

Brand names
Yunnan Baiyao
Other names
Yunnan PaiyaoYun Nan Bai YaoWhite medicine from the Province of Yunnan云南白药

Beyond the preview

Go deeper on Yunnan Baiyao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunnan Baiyao.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call